Dame Davies
Direttore/Membro del Consiglio presso UCB
Patrimonio netto: 3 462 $ in data 30/04/2024
Posizioni attive di Dame Davies
Società | Posizione | Inizio | Fine |
---|---|---|---|
UCB | Direttore/Membro del Consiglio | 01/01/2014 | - |
Independent Dir/Board Member | 01/01/2014 | - | |
OXFORD BIOMEDICA PLC | Direttore/Membro del Consiglio | 01/03/2021 | - |
Independent Dir/Board Member | 01/03/2021 | - | |
Genome Research Ltd.
Genome Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The Wellcome Trust Ltd., Genome Research Ltd. is a world-leading genomics research institute founded in 1992. The company is based in Cambridge, UK. Genome Research delivers therapeutic, diagnostic, and production benefits in areas such as cancer, immunology, public health, and personalized treatment. The British company tackle some of the most difficult challenges in genomic research, demanding science at scale and a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. The company's work helps improve human health and understand life on a molecular level. | Direttore/Membro del Consiglio | 08/12/2017 | - |
Oxstem Ltd.
Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Fondatore | - | - |
Storia della carriera di Dame Davies
Precedenti posizioni note di Dame Davies
Società | Posizione | Inizio | Fine |
---|---|---|---|
THE BIOTECH GROWTH TRUST PLC | Direttore/Membro del Consiglio | 15/03/2012 | 14/07/2021 |
Independent Dir/Board Member | 15/03/2012 | 14/07/2021 | |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Direttore/Membro del Consiglio | 01/01/2013 | 01/01/2017 |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Fondatore | 01/01/2003 | - |
University of Oxford | Corporate Officer/Principal | - | - |
Formazione di Dame Davies
University of Oxford | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 9 |
Belgio | 2 |
Posizioni
Director/Board Member | 6 |
Independent Dir/Board Member | 3 |
Founder | 2 |
Settori
Health Technology | 5 |
Miscellaneous | 3 |
Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
UCB | Health Technology |
OXFORD BIOMEDICA PLC | Health Technology |
Aziende private | 6 |
---|---|
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Miscellaneous |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
The Biotech Growth Trust Plc
The Biotech Growth Trust Plc Investment Trusts/Mutual FundsMiscellaneous The Biotech Growth Trust Plc is a closed-end investment trust. Its objective is to seek capital through investment in the worldwide biotechnology industry principally by investing in emerging biotechnology companies. The company was founded on May 20, 1997 by Christopher Thomas Evans and is headquartered in London, the United Kingdom. | Miscellaneous |
Genome Research Ltd.
Genome Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The Wellcome Trust Ltd., Genome Research Ltd. is a world-leading genomics research institute founded in 1992. The company is based in Cambridge, UK. Genome Research delivers therapeutic, diagnostic, and production benefits in areas such as cancer, immunology, public health, and personalized treatment. The British company tackle some of the most difficult challenges in genomic research, demanding science at scale and a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. The company's work helps improve human health and understand life on a molecular level. | Commercial Services |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Commercial Services |
Oxstem Ltd.
Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Dame Davies
- Esperienza